Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT

University Hospital, Montpellier28 enrolled

Overview

The aim of our study is to analyze pathological analysis of surgically treated aggressive hepatocellular carcinomas after radio-embolization. The investigators aim to demonstrate that a higher dose results in better tumor response while respecting safety conditions, that is, no radiologically induced liver disease.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hepatocellular Carcinoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: \- aggressive hepatocellular carcinomas with vascular invasion, large tumors or multifocal distribution Exclusion criteria: * Other treatment after SIRT (confounding effect) * contraindications for surgery

Locations (1)

Uhmontpellier

Montpellier, France

Outcomes

Primary Outcomes

Pathological tumor response

Patients are treated with SIRT, then if the tumor response was adequate, surgery was performed.Analysis after surgery. (6 months after SIRT)

Time frame: 6 months

Secondary Outcomes

Rate of Healthy liver hypertrophia

Time frame: day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.